Treatment of uterine fibroids by intravaginal administration of a low dose of a selective progesterone receptor modulator, an antigestagens or an antigestagen agent

摘要

An intravaginal drug delivery device comprising a selective progesterone receptor modulator (SPRM), wherein said delivery device (i) delivers said SPRM directly to the uterine fibroids and (ii) delivers a daily dose of said SPRM that ranges from 50 μg to 1 mg is.